Effect of bevacizumab on kruppel-like factor 2 in patients with metastatic colorectal, lung, or brain cancer.
Phase of Trial: Phase IV
Latest Information Update: 09 Mar 2015
At a glance
- Drugs Bevacizumab (Primary)
- Indications Adenocarcinoma; Brain cancer; Colorectal cancer; Non-small cell lung cancer
- Focus Biomarker; Pharmacodynamics
- 09 Mar 2015 New trial record